Neuroscience Today—June 17, 2026
This week’s Neuroscience update highlights regulatory decisions, late-stage…
Lucid Diligence Brief: Olema OP-3136 and Bayer Darolutamide Deal
Lucid Diligence Brief: Olema expands OP-3136 into metastatic…
Endocrinology Today—May 26, 2026
This week’s Endocrinology update highlights regulatory progress, reimbursement…
Oncology Today—May 25, 2026
This week’s Oncology update highlights regulatory progress, biomarker-driven…
Cardiovascular Today—May 21, 2026
This week’s Cardiovascular update highlights regulatory approvals, late-stage…
Oncology Today—May 18, 2026
This week’s Oncology update highlights regulatory approvals, breakthrough…
Lucid Diligence Brief: Bayer to Acquire Perfuse Therapeutics for Up to $2.45B
Lucid Diligence Brief: Bayer to Acquire Perfuse Therapeutics for Up to $2.45B…
Cardiovascular Today—April 23, 2026
This week’s Cardiovascular update highlights regulatory clearances, late-stage…
Cardiovascular Today—April 16, 2026
This week’s Cardiovascular update highlights regulatory approvals, pivotal…
Cardiovascular Video Recap—February 12, 2026
This biweekly Cardiovascular Video Recap covers late-stage clinical data,…
Cardiovascular Today—Februrary 12, 2026
This weekly Cardiovascular update covers clinical progress, guideline changes,…
Cardiovascular Video Recap—January 29, 2026
This biweekly Cardiovascular Video Recap reviews regulatory actions, late-stage…